Included Health launches alternative health plannews2026-01-28T15:02:39+00:00January 28th, 2026|Endpoints News|
Hengrui blazes trail as Chinese drugmakers aspire to go multinationalnews2026-01-28T15:00:06+00:00January 28th, 2026|Endpoints News|
Halozyme buys drug delivery biotech Surf Bio; Sanofi backs Sensorionnews2026-01-28T14:39:46+00:00January 28th, 2026|Endpoints News|
Cellares raises $257M to fund global expansion as it eyes 2027 IPOnews2026-01-28T12:00:48+00:00January 28th, 2026|Endpoints News|
Lilly partners with recombinase-based gene editing startup Seamless Therapeuticsnews2026-01-28T12:00:19+00:00January 28th, 2026|Endpoints News|
Boehringer Ingelheim takes rare kidney disease drug to Phase 3 despite puzzling mid-stage datanews2026-01-28T11:59:20+00:00January 28th, 2026|Endpoints News|
Updated: CMS picks Lilly’s Trulicity, Gilead’s Biktarvy for third round of Medicare negotiationsnews2026-01-27T22:26:48+00:00January 27th, 2026|Endpoints News|
Hospitals could earn more for buying US-made drugs, CMS proposesnews2026-01-27T20:05:47+00:00January 27th, 2026|Endpoints News|
Cardiff execs depart as company drops mixed Phase 2 datanews2026-01-27T18:22:21+00:00January 27th, 2026|Endpoints News|
